Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authorsvan Tonder, Andries J
Bray, James E
Quirk, Sigríður J
Jolley, Keith A
Maiden, Martin C J
Bentley, Stephen D
Kristinsson, Karl G
Brueggemann, Angela B
MetadataShow full item record
CitationJ. Clin. Microbiol. 2015, 53 (7):2271-85
AbstractThe pneumococcus is a leading pathogen infecting children and adults. Safe, effective vaccines exist, and they work by inducing antibodies to the polysaccharide capsule (unique for each serotype) that surrounds the cell; however, current vaccines are limited by the fact that only a few of the nearly 100 antigenically distinct serotypes are included in the formulations. Within the serotypes, serogroup 6 pneumococci are a frequent cause of serious disease and common colonizers of the nasopharynx in children. Serotype 6E was first reported in 2004 but was thought to be rare; however, we and others have detected serotype 6E among recent pneumococcal collections. Therefore, we analyzed a diverse data set of ∼1,000 serogroup 6 genomes, assessed the prevalence and distribution of serotype 6E, analyzed the genetic diversity among serogroup 6 pneumococci, and investigated whether pneumococcal conjugate vaccine-induced serotype 6A and 6B antibodies mediate the killing of serotype 6E pneumococci. We found that 43% of all genomes were of serotype 6E, and they were recovered worldwide from healthy children and patients of all ages with pneumococcal disease. Four genetic lineages, three of which were multidrug resistant, described ∼90% of the serotype 6E pneumococci. Serological assays demonstrated that vaccine-induced serotype 6B antibodies were able to elicit killing of serotype 6E pneumococci. We also revealed three major genetic clusters of serotype 6A capsular sequences, discovered a new hybrid 6C/6E serotype, and identified 44 examples of serotype switching. Therefore, while vaccines appear to offer protection against serotype 6E, genetic variants may reduce vaccine efficacy in the longer term because of the emergence of serotypes that can evade vaccine-induced immunity.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access.
RightsArchived with thanks to Journal of clinical microbiology
- Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E.
- Authors: Marimón JM, Ercibengoa M, Tamayo E, Alonso M, Pérez-Trallero E
- Issue date: 2016
- Capsular polysaccharide gene diversity of pneumococcal serotypes 6A, 6B, 6C, and 6D.
- Authors: Yun KW, Cho EY, Choi EH, Lee HJ
- Issue date: 2014 Nov
- Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi.
- Authors: Chaguza C, Cornick JE, Andam CP, Gladstone RA, Alaerts M, Musicha P, Peno C, Bar-Zeev N, Kamng'ona AW, Kiran AM, Msefula CL, McGee L, Breiman RF, Kadioglu A, French N, Heyderman RS, Hanage WP, Bentley SD, Everett DB
- Issue date: 2017 Aug 16
- Clinical and microbiological characterization of serotype 6D pneumococcal infections in South Korea.
- Authors: Cheong HJ, Song JY, Choi MJ, Jeon JH, Kang SH, Jeong EJ, Noh JY, Kim WJ
- Issue date: 2016 Aug
- Prevalence of isolates of Streptococcus pneumoniae putative serotype 6E in South Korea.
- Authors: Baek JY, Park IH, Song JH, Ko KS
- Issue date: 2014 Jun